Your browser doesn't support javascript.
loading
DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitro.
Guo, Xiao-Bin; Chen, Xian-Jie; Tong, Lin-Jiang; Peng, Xia; Huang, Min; Liu, Hong-Chun; Liu, Hong; Ding, Jian.
Affiliation
  • Guo XB; Department of Clinical Pharmacology, Xiangya Hospital and Institute of Clinical Pharmacology, Central South University, Changsha 410078, China.
  • Chen XJ; Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Tong LJ; CAS Key Laboratory of Receptor Research Shanghai 201203, China.
  • Peng X; Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Huang M; Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Liu HC; Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Liu H; Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Ding J; CAS Key Laboratory of Receptor Research Shanghai 201203, China.
Acta Pharmacol Sin ; 36(10): 1266-76, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26027659
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyridines / Receptor, ErbB-2 / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor Receptor-2 / Protein Kinase Inhibitors / ErbB Receptors Limits: Animals / Humans / Male Language: En Journal: Acta Pharmacol Sin Journal subject: FARMACOLOGIA Year: 2015 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyridines / Receptor, ErbB-2 / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor Receptor-2 / Protein Kinase Inhibitors / ErbB Receptors Limits: Animals / Humans / Male Language: En Journal: Acta Pharmacol Sin Journal subject: FARMACOLOGIA Year: 2015 Type: Article Affiliation country: China